Cargando…

ErbB2 and bone sialoprotein as markers for metastatic osteosarcoma cells

Osteosarcoma is the most common malignant bone neoplasia occurring in young patients in the first two decades of life, and represents 20% of all primitive malignant bone tumours. At present, treatment of metastatic osteosarcoma is unsatisfactory. High-dose chemotherapy followed by CD34+ leukapheresi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valabrega, G, Fagioli, F, Corso, S, Madon, E, Brach del Prever, A, Biasin, E, Linari, A, Aglietta, M, Giordano, S
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2003
Materias:	Molecular and Cellular Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747549/ https://www.ncbi.nlm.nih.gov/pubmed/12569382 http://dx.doi.org/10.1038/sj.bjc.6600735

Ejemplares similares

c-erbB-2 is not a major factor in the development of colorectal cancer
por: McKay, J A, et al.
Publicado: (2002)

Cellular responses to ErbB-2 overexpression in human mammary luminal epithelial cells: comparison of mRNA and protein expression
por: White, S L, et al.
Publicado: (2004)

Dominant negative knockout of p53 abolishes ErbB2-dependent apoptosis and permits growth acceleration in human breast cancer cells
por: Huang, G C, et al.
Publicado: (2002)

TP53 status determines clinical significance of ERBB2 expression in ovarian cancer
por: Kupryjańczyk, J, et al.
Publicado: (2004)

Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers
por: Vernimmen, D, et al.
Publicado: (2003)

Osteopontin expression correlates with adhesive and metastatic potential in metastasis-inducing DNA-transfected rat mammary cell lines
por: Moye, V E, et al.
Publicado: (2004)

Lymphatic density and metastatic spread in human malignant melanoma
por: Shields, J D, et al.
Publicado: (2004)

Prostate-Specific Ets (PSE) factor: a novel marker for detection of metastatic breast cancer in axillary lymph nodes
por: Mitas, M, et al.
Publicado: (2002)

Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer
por: Pierga, J-Y, et al.
Publicado: (2003)

The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer
por: de Graeff, P, et al.
Publicado: (2008)

Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer
por: Dirix, L Y, et al.
Publicado: (2002)

Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer
por: Ichikawa, W, et al.
Publicado: (2003)

Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients
por: Bachelot, T, et al.
Publicado: (2003)

Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer
por: Langelotz, C, et al.
Publicado: (2003)

Intratumoural and peripheral blood lymphocyte subsets in patients with metastatic renal cell carcinoma undergoing interleukin-2 based immunotherapy: association to objective response and survival
por: Donskov, F, et al.
Publicado: (2002)

Progress in the Research and Targeted Therapy of ErbB/HER Receptors in Urothelial Bladder Cancer
por: Chen, Dong, et al.
Publicado: (2021)

Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1
por: Li, Guangyuan, et al.
Publicado: (2014)

Engineered Bivalent Ligands to Bias ErbB Receptor-mediated Signaling and Phenotypes
por: Jay, Steven M., et al.
Publicado: (2011)

The functional significance of dentin sialoprotein-phosphophoryn and dentin sialoprotein
por: Ritchie, Helena
Publicado: (2018)

Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB.
por: Aasland, R., et al.
Publicado: (1988)

Computational design of fusion proteins against ErbB2-amplified tumors inspired by ricin toxin
por: Ahmadi Moghaddam, Yasser, et al.
Publicado: (2023)

Prediction of outcome in locally advanced breast cancer by post-chemotherapy nodal status and baseline serum tumour markers
por: Brenner, B, et al.
Publicado: (2002)

Epstein–Barr virus gene expression in human breast cancer: protagonist or passenger?
por: Xue, S A, et al.
Publicado: (2003)

Transcriptional impairment of β-catenin/E-cadherin complex is not associated with β-catenin mutations in colorectal carcinomas
por: Garinis, G A, et al.
Publicado: (2003)

Particulate debris from a titanium metal prosthesis induces genomic instability in primary human fibroblast cells
por: Coen, N, et al.
Publicado: (2003)

Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphoma
por: Pazgal, I, et al.
Publicado: (2002)

A prospective study of the relationship between prediagnostic Human Papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas
por: Sigstad, E, et al.
Publicado: (2002)

Transformation induced by Ewing's sarcoma associated EWS/FLI-1 is suppressed by KRAB/FLI-1
por: Chan, D, et al.
Publicado: (2003)

Potential use of the alkaline comet assay as a predictor of bladder tumour response to radiation
por: McKeown, S R, et al.
Publicado: (2003)

Kallikrein gene downregulation in breast cancer
por: Yousef, G M, et al.
Publicado: (2004)

Bone metastases from breast carcinoma: histopathological – radiological correlations and prognostic features
por: James, J J, et al.
Publicado: (2003)

The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer
por: Kaas, R, et al.
Publicado: (2003)

Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifen
por: Coradini, D, et al.
Publicado: (2003)

High level amplification of N-MYC is not associated with adverse histology or outcome in primary retinoblastoma tumours
por: Lillington, D M, et al.
Publicado: (2002)

Thyroid carcinoma after Chernobyl latent period, morphology and aggressiveness
por: Williams, E D, et al.
Publicado: (2004)

Prognostic factors for patients with hepatic metastases from breast cancer
por: Wyld, L, et al.
Publicado: (2003)

FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells
por: Sturla, L-M, et al.
Publicado: (2003)

Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes
por: Papadakis, E D, et al.
Publicado: (2002)

Carcinoma-like vascular density in atypic keratoacanthoma suggests malignant progression
por: Strieth, S, et al.
Publicado: (2002)

Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer
por: Yao, H, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_hchlrmhhu66nsbcdf81lbfn1od